Trial Profile
Postmarketing clinical study on AG-1749-clinical study on non-erosive reflux disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda
- 30 May 2016 New trial record